KLF1 drives the expression of fetal hemoglobin in British HPFH

Abstract

Key Points Introduction of the British HPFH mutation into the fetal globin promoter in a human cell model causes elevated fetal globin expression. The British HPFH mutation creates a de novo binding site both in vitro and in vivo for the potent erythroid activator KLF1.